Core Insights - Earth Science Tech, Inc. (ETST) has qualified for and been listed on the newly launched OTCID tier of the OTC Markets, reflecting its commitment to enhanced disclosure and compliance standards [1][2] - The CEO, Giorgio R. Saumat, highlighted the company's significant turnaround over the past two years and expressed optimism about future growth and increased investor confidence due to this new designation [3] Company Overview - ETST operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, with current operations in compounding pharmaceuticals, telemedicine, and real estate development through various subsidiaries [4] - The company's subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, each specializing in different aspects of healthcare and real estate [4][10] Subsidiary Highlights - **RxCompoundStore.com**: A fully licensed compounding pharmacy serving multiple states and actively pursuing licensure in remaining U.S. states [5] - **Mister Meds**: A compounding pharmacy in Texas that received full licensure in March 2025 and is expanding its service area [6] - **Peaks Curative**: A telemedicine platform offering consultations for compounded medications and recently expanded into the veterinary market [7] - **Las Villas Health Care**: A healthcare facility focused on the Spanish-speaking community, providing specialized health services [8] - **Avenvi**: A diversified real estate company managing development and financing activities, overseeing a $5 million share repurchase program [10] - **Earth Science Foundation**: A nonprofit organization supporting individuals with financial needs for prescription costs [11]

Miami, FL, June 26, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses, today shares its financial results for the year ended March 31, 2025. For the fiscal year ended March 31, 2025, the Company reported the following results: Cash: $1,473,228, compared to $697,721 as of March 31, 2024—an increase of $775,507, representing a 1 ...

Starlink's reliable high-speed internet connects remote parts of the world to vital telemedicine 🛰️🩺19Labs (@19_labs):Another wonderful day in the field! Today, we visited Agua del Sol (pop. 840), where an advanced caravan has been visiting for 3 days. 🩺🇲🇽Already equipped with general medicine and dental consults, they now also have a fully functioning telemedicine set up thanks to #Starlink https://t.co/Z4Fm1KZolP ...

Hims & Hers Health shares rocketed higher over the last year, rewarding investors. When it comes to healthcare stocks, many investors pay attention to the usual suspects: Eli Lilly, Novo Nordisk, CVS Health, or Johnson & Johnson. These companies have built up enormous brand equity thanks to blockbuster drugs and widely recognized pharmacy management services. What does Oscar Health do, and why might it draw comparisons to Hims & Hers? When it comes to accessing patient care, consumers have a couple of optio ...

Company Overview - Hims & Hers Health is a telemedicine platform providing access to various medications, including those for skin care, anxiety, sexual health, and weight loss [4] - The company operates on a subscription model, boasting 2.4 million subscribers at the end of Q1, representing a 38% year-over-year increase [5] - Revenue for the quarter reached $586 million, reflecting a remarkable 111% year-over-year growth [5] Business Model and Strategy - The subscription revenue model allows for high gross margins and recurring income [6] - By maintaining a primarily online business, Hims & Hers can reduce marketing expenses and invest in technology and research and development [6] - The company is focusing on AI investments to better understand customer data and unlock new expansion opportunities [7] Market Performance and Analyst Sentiment - Hims & Hers shares have increased by 157% over the past year, outperforming the market [2] - Despite the company's growth, Wall Street analysts have maintained neutral to bearish ratings, with no compelling buy ratings from major banks [10] - The average price estimate among analysts is approximately $48, indicating a potential 12% downside from current trading levels [10] Short Interest and Volatility - Approximately 35% of Hims & Hers' float is sold short, which is significantly higher than the typical benchmark of 10% [13] - High short interest can lead to increased volatility and potential short squeezes, contributing to stock price fluctuations [14] - The stock's volatility raises concerns about its suitability as a long-term investment [15] Investment Outlook - Hims & Hers represents a compelling opportunity at the intersection of healthcare and technology, with strong user acquisition and monetization capabilities [16] - The potential of AI in healthcare supports the company's long-term growth vision [17] - However, the stock's behavior resembles that of a meme stock, suggesting it may be more suitable for swing trading rather than a solid long-term investment [18][19]

Core Insights - The event hosted by GeeVida Health and Life Time focuses on longevity science and holistic health, featuring industry leaders sharing strategies for healthy living and aging [1][2] - GeeVida Health is a concierge telemedicine platform that emphasizes personalized care and health optimization, offering services for various health conditions [3] - Life Time operates a network of athletic country clubs and wellness programs, promoting healthy living and aging through a comprehensive ecosystem [4][5] Group 1: Event Details - The event will take place on June 14, 2025, at the UC Irvine Beall Applied Innovation Center, running from 9:00 a.m. to 5:30 p.m. [1] - Attendees will have networking opportunities with industry specialists and access to exhibitors showcasing performance and longevity innovations [2] Group 2: Key Speakers and Topics - Dr. Kambiz Farbakhsh will discuss the science behind aging well and future human performance [4] - Bahram Akradi will share insights on breakthroughs in longevity [4] - James LaValle will present a blueprint for lifelong health [4] - Other speakers include experts on the mind-body connection, nutritional strategies, and holistic wellness approaches [4] Group 3: Company Profiles - GeeVida Health provides state-of-the-art telemedicine services focused on health optimization and chronic disease management, ensuring personalized care [3] - Life Time operates 180 athletic country clubs and offers a range of wellness programs, recently recognized as a Great Place to Work® [5]

Core Insights - Mobile-health Network Solutions (MNDR) has launched a new tele-dentistry service that allows patients to perform AI-enhanced dental scans at home using the MNDR telemedicine app, with expert-reviewed reports delivered within 24 hours [2][3][4] - The service aims to encourage Southeast Asian patients, who often do not visit dentists regularly, to seek dental care more frequently [3][7] - The tele-dentistry package includes guided steps for capturing intraoral images and receiving AI-generated reports, which will highlight potential dental issues [4][5] Company Developments - MNDR has signed a Memorandum of Understanding (MOU) with Oral Link Pte Ltd and Elite Dental Group Singapore Pte Ltd to facilitate the tele-dentistry service [4][6] - The service is set to launch in Singapore in the summer of 2025, with plans for expansion into Malaysia, Indonesia, and the Philippines by mid-2026 [6] - MNDR will earn an appointment booking fee and platform usage fee for each tele-dentistry session [6] Industry Context - According to the World Health Organization, oral diseases affect nearly 3.7 billion people globally, with untreated dental caries being the most common health condition [9] - The introduction of AI-enabled dental scans is expected to improve early detection of dental issues, potentially increasing patient engagement in dental care [7][9]

Core Viewpoint - Mobile-health Network Solutions (MNDR) has announced a new tele-dentistry service that utilizes AI-enabled dental scans, aimed at improving dental care accessibility in Southeast Asia, particularly for patients who do not regularly visit dentists [1][2][6]. Company Overview - MNDR is a leading MedTech innovator ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies and is the first telehealth provider from the Asia-Pacific region to be listed in the US [9]. Service Details - The new tele-dentistry service will allow patients to perform AI-enhanced dental scans at home using the MaNaDr telemedicine app, with expert-reviewed reports delivered within 24 hours [1][3]. - Patients can purchase a tele-dentistry package through the app, capture intraoral images with their smartphones, and receive detailed AI-generated reports highlighting potential dental issues [3][4]. - The service will launch in Singapore in summer 2025, with plans for expansion to Malaysia, Indonesia, and the Philippines by mid-2026 [5]. Market Need - The service targets the significant population in Southeast Asia that does not visit a dentist at least once a year, potentially at higher risk for dental conditions [6][7]. - According to the World Health Organization, oral diseases affect nearly 3.7 billion people globally, with untreated dental caries being the most common health condition [7]. Revenue Model - MNDR will earn an appointment booking fee and platform usage fee for each tele-dentistry session conducted through the MaNaDr app [5].

Concentra Group Holdings Parent (CON) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Keith Newton - CEOMatthew DiCanio - President & CFOBenjamin Rossi - Equity Research AssociateBen Hendrix - Vice PresidentEdward Kressler - Managing Director Conference Call Participants Jamie Perse - AnalystJoanna Gajuk - Equity Research AnalystStephen Baxter - Senior Equity Research AnalystJustin Bowers - Analyst Operator Good morning and thank you for joining us today for Concentra Group Holdings Pare ...

Justin Schreiber, Chairman and CEO of LifeMD, said, "LifeMD had an outstanding first quarter that demonstrated the power of our platform, the need for our services and the accelerated growth trajectory of the business as we achieved our first-ever quarter of GAAP profitability well ahead of expectations. During the quarter we expanded across all service areas, and the performance of our weight management program underscored our success as it is now expected to exceed top- and bottom-line expectations for th ...